On January 4, 2024 AtriCure, Inc. filed a Current Report on Form 8-K reporting that the Company?s Board of Directors elected Shlomi Nachman to serve as a director until the Company?s next Annual Meeting of Stockholders. This Current Report on Form 8-K amends the Original Form 8-K for the purpose of reporting that effective February 22, 2024, the Board elected Mr. Nachman to serve as a member of each of the Board?s Strategy Committee and Compliance, Quality and Risk Committee.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
23.84 USD | +2.87% | +3.79% | -33.96% |
Apr. 23 | Oppenheimer Upgrades AtriCure to Outperform, Price Target at $32 | MT |
Apr. 18 | AtriCure, Inc. Announces Launch of the CryoSPHERE®?+ Probe for Post-Operative Pain Management | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.96% | 1.12B | |
-2.09% | 187B | |
-2.39% | 106B | |
-4.21% | 66.9B | |
+1.89% | 49.45B | |
+16.82% | 48B | |
+4.06% | 40.84B | |
+3.17% | 26.48B | |
+1.31% | 26.25B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- ATRC Stock
- News AtriCure, Inc.
- Atricure, Inc. Appoints Shlomi Nachman as Director, Member of Each of the Board?s Strategy Committee and Compliance, Quality and Risk Committee